1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Haemonetics Corp.

Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
Christopher Simon

125 Summer Street
Boston, Massachusetts 02110
Phone: 17818487100


Haemonetics Corporation (HAE) Q2 2023 Earnings Call Transcript
Nov 07, 2022 16:17pm

Haemonetics Corporation (NYSE:NYSE:HAE) Q2 2023 Earnings Conference Call November 7, 2022 8:00 a.m.

Source:Seeking Alpha
Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
Nov 07, 2022 11:00am

Financial release accessible online BOSTON , Nov. 7, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that financial results for its second quarter fiscal 2023, which ended October 1, 2022 , are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2022 . The conference call and webcast can be accessed with the following … Full story available on Benzinga.com

Haemonetics Q2 2023 Earnings Preview (NYSE:HAE)
Nov 04, 2022 16:44pm

Haemonetics (HAE) is scheduled to announce Q2 earnings results on Sunday, November 6th, before market open.The consensus EPS Estimate is $0.67 (+11.7% Y/Y) and the consensus…

Source:Seeking Alpha
Buy - Victory Capital Management Inc. Raises Position in Haemonetics Co
Oct 24, 2022 13:07pm

Victory Capital Management Inc. grew its position in Haemonetics Co. by 808.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 377,252…

Source:Business Mag